The prevalence of illicit drug use in intensive cardiac care unit ICCU patients

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-08-27 03:45 GMT   |   Update On 2022-08-27 03:45 GMT

Illicit drug use is associated with a nearly nine-fold greater risk of death or life-threatening emergencies in intensive cardiac care unit (ICCU) patients, according to research presented at ESC Congress 2022.The ADDICT-ICCU study assessed the prevalence of illicit drug use and the association with in-hospital major adverse events in consecutive patients admitted for acute cardiovascular...

Login or Register to read the full article
Illicit drug use is associated with a nearly nine-fold greater risk of death or life-threatening emergencies in intensive cardiac care unit (ICCU) patients, according to research presented at ESC Congress 2022.
The ADDICT-ICCU study assessed the prevalence of illicit drug use and the association with in-hospital major adverse events in consecutive patients admitted for acute cardiovascular events. From 7 to 22 April 2021, all consecutive patients admitted to ICCU in 39 centers throughout France provided a urine sample tested for illegal drugs.
A total of 1,499 patients were screened. Reasons for admission included myocardial infarction, acute heart failure, arrhythmias, myocarditis, and pulmonary embolism.10.7% had a positive test for at least one illicit drug.
Patients who used illicit drugs tended to be young:33% of patients under 40 years of age were users compared with just 6% of those aged 60 years or above.
During a median hospitalization of five days, 4.1% had a major adverse event. Illicit drug use was associated with an almost nine-fold odds of major adverse events after adjusting for comorbidities. After adjustment for age and sex, cannabis use was associated with a three-fold odds of major adverse events while cocaine was associated with a five-fold odds. Of those using drugs, 28% took more than one type of drug. Multiple drug use was associated with a higher incidence of major adverse events than single drug use.
Ref:
Dr. Theo Pezel et al, ESC Congress 2022.

Tags:    
Article Source : ESC

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News